Brevan Howard Capital Management LP

Q2 2022 13F Holdings Report, Stock Holdings

Signature - Title
Donal Reamonn O'Sullivan - Head of Compliance
Location
St. Helier, Jersey
Holdings as of
30 Jun 2022
Value $
$136,721,000
Num holdings
36
Filing time
15 Aug 2022, 16:37:12 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included MRNA, URA, CME, TRTX, and CNDWS.
Previous filing
Q1 2022 - 16 May 2022
Next filing
Q3 2022 - 14 Nov 2022
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q2 compared to 2022 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Donal Reamonn O'Sullivan Head of Compliance St Helier, Jersey 15 Aug 2022

*NOTE: The investment manager filing this report is deemed to have investment discretion with respect to securities over which Brevan Howard (Hong Kong) Limited ("BHHK"), Brevan Howard Investment Products Limited ("BHIPL"), Brevan Howard Cayman SEZC Limited ("BHCSL"), Brevan Howard Asset Management LLP ("BHAM"), Brevan Howard US Investment Management LP ("BHUS") and Brevan Howard Private Limited ("BHPL"), subsidiaries of the investment manager, exercise investment discretion as a result of the investment manager having control over BHHK, BHIPL, BHCSL, BHAM, BHUS and BHPL.